KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Acquisitions (2016 - 2019)

Bausch Health Companies' Acquisitions history spans 10 years, with the latest figure at $180.0 million for Q1 2019.

  • For Q1 2019, Acquisitions rose 3700.0% year-over-year to $180.0 million; the TTM value through Dec 2019 reached $180.0 million, up 3700.0%, while the annual FY2023 figure was $1.9 billion, 4100.0% up from the prior year.
  • Acquisitions for Q1 2019 was $180.0 million at Bausch Health Companies, up from -$5.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $13.1 billion in Q2 2015 and bottomed at -$5.0 million in Q1 2018.
  • The 4-year median for Acquisitions is $180.0 million (2019), against an average of $2.2 billion.
  • The largest annual shift saw Acquisitions surged 19151.32% in 2015 before it plummeted 97.61% in 2016.
  • A 4-year view of Acquisitions shows it stood at $1.5 billion in 2015, then crashed by 98.7% to $19.0 million in 2016, then tumbled by 126.32% to -$5.0 million in 2018, then soared by 3700.0% to $180.0 million in 2019.
  • Per Business Quant, the three most recent readings for BHC's Acquisitions are $180.0 million (Q1 2019), -$5.0 million (Q1 2018), and $19.0 million (Q1 2016).